Why Valero Energy Corporation, Phillips 66, and Vertex Pharmaceuticals Incorporated Are Today's 3 Worst Stocks

Today investors learned that the U.S. economy was absolutely abysmal in the first quarter of 2014. Far exceeding even the most bearish estimates, gross domestic product actually contracted by 2.9% in the January-March period, the steepest setback since the depths of the recession in 2009. You'd think that the stock market would enter freefall mode on that revelation, but instead it was only a handful of stocks -- Valero Energy Corporation (NYSE: VLO  ) , Phillips 66 (NYSE: PSX  ) , and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX  ) -- that were freefalling. The S&P 500 Index (SNPINDEX: ^GSPC  ) actually managed to add 9 points, or 0.5%, to end at 1,959.

Valero Energy shed 8.3%, finishing as the worst performer in the 500-stock index Wednesday, as sudden, sweeping structural reforms that change 40-year-old rules on exporting oil hit shares of U.S. refiners. According to a Wall Street Journal report late yesterday, the Commerce Department is allowing several U.S. oil companies to export unrefined condensate oil overseas. That sort of exporting hasn't been allowed since the '70s, giving U.S. refiners a monopoly on the refinery business. Valero is strictly a refining and marketing company, so the decision clearly threatens its business.

Source: Phillips 66

Thankfully for Phillips 66 investors, this company is more diversified, engaging in the transport of oil and natural gas, producing chemicals, and hawking specialty products like solvents and waxes. That said, since its foundation nearly 140 years ago, Phillips 66 has evolved around its refinery business, so the news sent shares down 4.2% Wednesday. Its transportation business, for instance, often hauls gas that it has just refined to the end-customers. With oil producers now permitted to ship unrefined oil abroad without paying for any distillation process, Phillips 66 is still in a tough spot.

Lastly, shares of Vertex Pharmaceuticals fell 3.9% today. If you're a Vertex shareholder, odds are today's little stumble doesn't even register as a concern on the radar. That's because the stock soared a phenomenal 40% yesterday after data for its "TRAFFIC" and "TRANSPORT" trials met the company's goals. Vertex is trying to use a combination of its cystic fibrosis drug, Kalydeco, and another drug, lumacaftor, to gain approval from regulators to market the combo as a treatment that improves lung function in certain cystic fibrosis patients. The newest data make it look like such an approval is very likely to occur in the future.

Do you know this energy tax "loophole"?
You already know record oil and natural gas production is changing the lives of millions of Americans. But what you probably haven't heard is that the IRS is encouraging investors to support our growing energy renaissance, offering you a tax loophole to invest in some of America's greatest energy companies. Take advantage of this profitable opportunity by grabbing your brand-new special report, "The IRS Is Daring You to Make This Investment Now!," and you'll learn about the simple strategy to take advantage of a little-known IRS rule. Don't miss out on advice that could help you cut taxes for decades to come. Click here to learn more.

Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 26, 2014, at 7:48 AM, assisgnmeaname wrote:

    "Valero Energy shed 8.3%, finishing as the worst performer in the 500-stock index Wednesday, as sudden, sweeping structural reforms that change 40-year-old rules on exporting oil hit shares of U.S. refiners."

    Really? Sweeping structural reforms??

    The white house denies there was even an incremental change in policy, let alone "sweeping

    changes" do you justify this erroneous hyperbole to retail investors who may not know better?

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3008610, ~/Articles/ArticleHandler.aspx, 9/2/2015 1:19:20 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

John Divine

Fool since 2012, unique fingerprints since birth. Age 7: Put lifetime savings ($18.37!) in the bank, became disillusioned with low interest, and a fascination with the stock market was born.

Today's Market

updated Moments ago Sponsored by:
DOW 16,246.05 187.70 1.17%
S&P 500 1,931.96 18.11 0.95%
NASD 4,694.99 58.88 1.27%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/2/2015 1:09 PM
^GSPC $1931.72 Up +17.87 +0.93%
S&P 500 INDEX CAPS Rating: No stars
PSX $77.75 Up +0.16 +0.21%
Phillips 66 CAPS Rating: *****
VLO $58.20 Up +0.80 +1.39%
Valero Energy Corp CAPS Rating: ****
VRTX $125.53 Up +1.49 +1.20%
Vertex Pharmaceuti… CAPS Rating: ***